John Wilkinson's Colleagues at Noxopharm Limited
John Wilkinson's Contact Details
HQ
61-2-9144-2223
61-2-9144-2223
Location
Sydney, New South Wales, Australia
Sydney, New South Wales, Australia
Company
Noxopharm Limited
Noxopharm Limited
John Wilkinson's Company Details
Noxopharm (ASX:NOX) is an Australian-based clinical-stage drug development company with offices in Sydney and New York. Veyonda is the first pipeline drug candidate which is being trialed as a treatment for a broad range of solid tumor cancers and for septic shock. Later generation drug candidates for large markets of unmet medical need such as brain and pancreatic cancer are being developed in an active R&D program. The fully-owned subsidiary, Pharmorage Pty Ltd, was created in 2020 and has a focus on inflammation and autoimmune diseases.Likes and shares are not endorsements
Frequently Asked Questions about John Wilkinson
John Wilkinson currently works for Noxopharm Limited.
John Wilkinson's role at Noxopharm Limited is Chief Scientific Officer.
John Wilkinson's email address is ***@noxopharm.com. To view John Wilkinson's full email address, please signup to ConnectPlex.
John Wilkinson works in the BioTech/Drugs industry.
John Wilkinson's colleagues at Noxopharm Limited are Renaud Quantin, Renaud Quantin, Mark Waring, Graham PhD, Brett Samuel, Susan Williams, Boris Patkin and others.
John Wilkinson's phone number is 61-2-9144-2223